Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus

被引:88
|
作者
Kreijtz, J. H. C. M. [1 ]
Bodewes, R. [1 ]
van den Brand, J. M. A. [1 ]
de Mutsert, G. [1 ]
Baas, C. [1 ]
van Amerongen, G. [1 ]
Fouchier, R. A. M. [1 ]
Osterhaus, A. D. M. E. [1 ]
Rimmelzwaan, G. F. [1 ]
机构
[1] Erasmus MC, Dept Virol, NL-3000 CA Rotterdam, Netherlands
关键词
Influenza virus; Heterosubtypic immunity; Cytotoxic T lymphocytes; CD8(+) T-CELLS; A VIRUS; HETEROSUBTYPIC IMMUNITY; HETEROTYPIC IMMUNITY; LYMPHOCYTES-T; M2; PROTEIN; HONG-KONG; H5N1; VACCINE; NUCLEOPROTEIN;
D O I
10.1016/j.vaccine.2009.05.079
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The transmission of highly pathogenic avian influenza (HPAI) A viruses of the H5N1 subtype from poultry to man and the high case fatality rate fuels the fear for a pandemic outbreak caused by these viruses. However, prior infections with seasonal influenza A/H1N1 and A/H3N2 viruses induce heterosubtypic immunity that could afford a certain degree of protection against infection with the HPAI A/H5N1 viruses, which are distantly related to the human influenza A viruses. To assess the protective efficacy of such heterosubtypic immunity mice were infected with human influenza virus A/Hong Kong/2/68 (H3N2) 4 weeks prior to a lethal infection with HPAI virus A/Indonesia/5/05 (H5N1). Prior infection with influenza virus A/Hong Kong/2/68 reduced clinical signs, body weight loss, mortality and virus replication in the lungs as compared to naive mice infected with HPAI virus A/Indonesia/5/05. Priming by infection with respiratory syncytial virus, a non-related virus did not have a beneficial effect on the outcome of A/H5N1 infections, indicating that adaptive immune responses were responsible for the protective effect. In mice primed by infection with influenza A/H3N2 virus cytotoxic T lymphocytes (CTL) specific for NP366-374 epitope ASNENMDAM and PA(224-232) SCLENFRAYV were observed. A small proportion of these CTL was cross-reactive with the peptide variant derived from the influenza A/H5N1 virus (ASNENMEVM and SSLENFRAYV respectively) and upon challenge infection with the influenza A/H5N1 virus cross-reactive CTL were selectively expanded. These CTL, in addition to those directed to conserved epitopes, shared by the influenza A/H3N2 and A/H5N1 viruses, most likely contributed to accelerated clearance of the influenza A/H5N1 virus infection. Although also other arms of the adaptive immune response may contribute to heterosubtypic immunity, the induction of virus-specific CTL may be an attractive target for development of broad protective vaccines. Furthermore the existence of pre-existing heterosubtypic immunity may dampen the impact a future influenza pandemic may have. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4983 / 4989
页数:7
相关论文
共 50 条
  • [31] Protection of cats against lethal influenza H5N1 challenge infection
    Vahlenkamp, Thomas W.
    Harder, Timm C.
    Giese, Matthias
    Lin, Fengsheng
    Teifke, Jens P.
    Klopfleisch, Robert
    Hoffmann, Ralf
    Tarpey, Ian
    Beer, Martin
    Mettenleiter, Thomas C.
    JOURNAL OF GENERAL VIROLOGY, 2008, 89 : 968 - 974
  • [32] Subclinical infection with avian influenza A (H5N1) virus in cats
    Leschnik, Michael
    Weikel, Joachim
    Moestl, Karin
    Revilla-Fernandez, Sandra
    Wodak, Eveline
    Bago, Zoltan
    Vanek, Elisabeth
    Benetka, Viviane
    Hess, Michael
    Thalhammer, Johann G.
    EMERGING INFECTIOUS DISEASES, 2007, 13 (02) : 243 - 247
  • [33] Monoclonal Antibodies against the Fusion Peptide of Hemagglutinin Protect Mice from Lethal Influenza A Virus H5N1 Infection
    Prabhu, Nayana
    Prabakaran, Mookkan
    Ho, Hui-Ting
    Velumani, Sumathy
    Qiang, Jia
    Goutama, Michael
    Kwang, Jimmy
    JOURNAL OF VIROLOGY, 2009, 83 (06) : 2553 - 2562
  • [34] Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection
    Ibanez, Lorena Itati
    De Filette, Marina
    Hultberg, Anna
    Verrips, Theo
    Temperton, Nigel
    Weiss, Robin A.
    Vandevelde, Wesley
    Schepens, Bert
    Vanlandschoot, Peter
    Saelens, Xavier
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (08): : 1063 - 1072
  • [35] Update on Avian Influenza A (H5N1) virus infection in humans
    Abdel-Ghafar, Abdel-Nasser
    Chotpitayasunondh, Tawee
    Gao, Zhancheng
    Hayden, Frederick G.
    Hien, Nguyen Duc
    de Jong, Menno D.
    Naghdaliyev, Azim
    Peiris, J. S. Malik
    Shindo, Nahoko
    Soeroso, Santoso
    Uyeki, Timothy M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (03): : 261 - 273
  • [36] Pathogenesis of influenza A (H5N1) virus infection in a primate model
    Rimmelzwaan, GF
    Kuiken, T
    van Amerongen, G
    Bestebroer, TM
    Fouchier, RAM
    Osterhaus, ADME
    JOURNAL OF VIROLOGY, 2001, 75 (14) : 6687 - 6691
  • [37] Invasive Aspergillosis as a Complication of Influenza Virus H3N2 Infection
    Garcia Clemente, Marta
    Martin Iglesias, Lorena
    Enriquez Rodriguez, Ana Isabel
    Iscar Urrutia, Marta
    Madrid Carbajal, Claudia
    Lopez Gonzaleza, Francisco Julian
    ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (06): : 406 - 408
  • [38] Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice
    Gubareva, LV
    McCullers, JA
    Bethell, RC
    Webster, RG
    JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06): : 1592 - 1596
  • [39] INFECTION OF HORSES WITH EQUINE INFLUENZA A1 AND HUMAN A(H3N2) VIRUS IN HUNGARY
    ROMVARY, J
    TANYI, J
    MATHE, Z
    ACTA MICROBIOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE, 1975, 22 (03): : 333 - 334
  • [40] Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1
    Kendirgi, Frederic
    Yun, Nadezda E.
    Linde, Nathaniel S.
    Zacks, Michele A.
    Smith, Jeanon N.
    Smith, Jennifer K.
    McMicken, Harilyn
    Chen, Yin
    Paessler, Slobodan
    HUMAN VACCINES, 2008, 4 (06): : 410 - 419